Factor VIII Deficiency Treatment Market, Dynamics, Trends, Market Analysis

1
Presents a Research Report on
Factor VIII Deficiency Treatment Market
The report on the Global Factor VIII Deficiency
Treatment Market, By Type (Haemophilia A Drugs,
Haemophilia A Inhibitors Treatment, Von
Willebrand Disease Treatment), By Application
(Hospitals, Clinics, Others), and Region. This
report also covers the COVID-19 Impact Analysis
and Forecast to 2026.


www.stratviewresearch.com
Market Reports
Advisory Consulting
Sourcing Intelligence
2
Factor VIII Deficiency Treatment Market Growth
and Forecast Highlights Drivers

• The Global Factor VIII Deficiency Treatment
  Market is projected to grow at a CAGR of over
  5.7 during the forecast period.
• Factor VIII is a vital blood-clotting protein,
  which is also known as an antihemophilic factor.
• In individuals, the factor VIII is mainly encoded
  by the F8 gene.
• The defects in this gene lead to haemophilia A,
  which is a recessive X-linked coagulation
  disorder.
• Factor VIII has been generated in liver
  sinusoidal cells and endothelial cells outside
  the liver around the body.
• This protein primarily mixes in the bloodstream
  in an inactive form and binds to another molecule
  called the von Willebrand factor, until damage to
  blood vessels occurs.
• In response to injury, coagulation factor VIII is
  quickly activated, and it separates from the von
  Willebrand factor.
• Target Audience
• The following is a list of the customers that the
  Factor VIII Deficiency Treatment Market aims to
  convert the most
• Factor VIII deficiency treatment companies
• Drug companies
• Hospitals
• Medical devices companies
• RD centers

3
Market Insights

• Market Dynamics
• The rising incidence of haemophilia A, growing
  adoption of prophylactic treatment, and the
  development of novel drugs with extended actions
  are some of the key factors augmenting the market
  growth.
• Also, rising demand for novel recombinant
  extended half-life products, launch of
  plasma-derived products for recombinant factor
  VIII at low costs, and the emergence of
  monoclonal antibodies as well as gene therapy
  products further bolster the product demand.
• In addition, favourable government guidelines and
  scenarios for the product treatment and launches
  are some of the additional driving factors.
• COVID-19 Impact on Global Telemedicine Market
  (Tele-home and Tele-hospital Market)
• The outbreak of the COVID-19 virus has negatively
  influenced the Factor VIII Deficiency Treatment
  industry. Government bodies across the globe are
  focusing to curb the COVID-19 with stringent
  measures, such as nationwide lockdowns, social
  distancing, and large-scale quarantine to prevent
  the spread of the coronavirus. Due to the
  outbreak of the coronavirus disease COVID-19, the
  medical visits were either cancelled or
  postponed, which, in turn, hampered the market
  growth.

4
Market Insights

• By Type
• Based on Type, the factor VIII deficiency
  treatment market has been bifurcated into
  haemophilia A drugs, haemophilia A inhibitors
  treatment, and von Willebrand disease treatment.
• Under these, the haemophilia A drugs segment
  garnered the largest market share in 2020 and is
  projected to grow at the highest CAGR during the
  review period.
• Haemophilia A is one of the most common blood
  disorders and the prevalence rate is high in
  emerging and underdeveloped countries across the
  globe.
• As per the recent statistics, around 19,000
  people in India suffer from haemophilia and only
  15 of the patients are registered, thus boosts
  the need for haemophilia A drugs.
• By Region
• The North America market garnered the largest
  market share in 2020 and is projected to grow at
  a steady CAGR during the assessment period.
• The US is a key country for haemophilia
  treatment.
• According to the Haemophilia Federation of
  America, haemophilia A affects around 1 in 5,000
  people in the U.S. and approximately 400
  new-borns are diagnosed with haemophilia every
  year.
• Also, presence of favourable reimbursement and
  insurance in the country will result in growing
  demand and adoption rate of haemophilia
  medications, expanding the haemophilia treatment
  market growth in the country.

5
Competitive Insights
Factor VIII Deficiency Treatment Market, regional
expansion, and execution of mergers
acquisitions are the key strategies adopted by
the major players to gain a competitive edge in
the market. Key Companies Analysed

• Pfizer (The U.S)
• Takeda (Japan)
• Bayer HealthCare (Germany)
• CSL (The U.S)
• Grifols (Spain)
• Novo Nordisk (Denmark)
• F. Hoffmann-La Roche (Switzerland)
• Kedrion (Italy)
• Octapharma (Switzerland)
• Biogen Idec (The U.S).

6
Research Methodology
Data Analysis Top Down and Bottom Up Approach)
Data Triangulation Data Evaluation and Multiple
Data Triangulation)
Final Deliverables Final Report with All Findings)
Stratview Research follows a rigorous methodology
with high emphasis on primary research and
multiple ways of data triangulation. We conduct
primary research across the value chain to
provide 360 degree view of the market.
Secondary Research
Stratview Research Internal Knowledgebase
Primary Research

• Annual Reports / Fact Book
• Company Websites
• Magazines / Publications
• Press Releases Journals
• Industry News
• Association Articles
• Government Documents
• Social Media
• Others

• Robust database across value chain
• In-house industry veterans as advisors
• Project based subject matter experts

• Industry Players
• Industry Experts
• Suppliers
• Customers
• Associations
• Government Institutions
• Others

7
Report Features

• This report provides market intelligence in the
  most comprehensive way. The report structure has
  been kept such that it offers maximum business
  value. It provides critical insights on the
  market dynamics and will enable strategic
  decision making for the existing market players
  as well as those willing to enter the market. The
  following are the key features of the report
• Market structure Overview, industry life cycle
  analysis, supply chain analysis.
• Market environment analysis Growth drivers and
  constraints, Porters five forces analysis, SWOT
  analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics Market share,
  product portfolio, product launches, etc.
• Attractive market segments and associated growth
  opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing
  and new players.
• Key success factors.

8
About Stratview Research
Stratview Research is a global market
intelligence firm providing high quality
syndicated reports, custom research and
consulting services.
Our Services
Why Us?
High Customer Delight
Rich Industry Experience
Robust Methodology
Effective Business Decisions
9
Contact Us for More Information and Sample Pages
Ask for Sample Pages here https//www.stratviewr
esearch.com/Request-Sample/1858/factor-VIII-defici
ency-treatment-market.htmlform
10
Thank You